Consolidated Investment Group LLC Reduces Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Consolidated Investment Group LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 6.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 16,535 shares of the healthcare conglomerate’s stock after selling 1,065 shares during the period. UnitedHealth Group makes up 1.5% of Consolidated Investment Group LLC’s investment portfolio, making the stock its 15th largest position. Consolidated Investment Group LLC’s holdings in UnitedHealth Group were worth $8,705,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Richelieu Gestion SA purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $26,000. Robbins Farley bought a new position in shares of UnitedHealth Group during the third quarter valued at about $25,000. CGC Financial Services LLC lifted its stake in shares of UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares during the last quarter. NewSquare Capital LLC lifted its position in UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares during the last quarter. Finally, Strategic Investment Solutions Inc. IL purchased a new position in shares of UnitedHealth Group in the first quarter worth $35,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded up $1.60 during midday trading on Thursday, hitting $494.70. 3,805,551 shares of the stock traded hands, compared to its average volume of 4,097,774. The firm has a 50-day moving average of $503.10 and a two-hundred day moving average of $518.61. The firm has a market capitalization of $456.08 billion, a P/E ratio of 20.70, a PEG ratio of 1.34 and a beta of 0.54. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm had revenue of $94.43 billion for the quarter, compared to analysts’ expectations of $92.13 billion. During the same period in the prior year, the firm earned $5.34 EPS. The company’s revenue was up 14.1% compared to the same quarter last year. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. UnitedHealth Group’s dividend payout ratio is currently 31.54%.

Insider Buying and Selling

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

Analyst Ratings Changes

A number of research firms have recently weighed in on UNH. HSBC reiterated a “reduce” rating and set a $480.00 target price (down from $550.00) on shares of UnitedHealth Group in a report on Monday, December 18th. Oppenheimer reiterated an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. Royal Bank of Canada restated an “outperform” rating and issued a $596.00 price objective on shares of UnitedHealth Group in a report on Thursday, February 29th. Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a report on Friday, January 19th. Finally, Barclays started coverage on UnitedHealth Group in a report on Wednesday, March 6th. They set an “overweight” rating and a $551.00 target price on the stock. One investment analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $579.33.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.